Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Gemcitabine × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 21 Head & Neck 9 Gastrointestinal 6 Gynecologic 5 Thoracic 3 Genitourinary 3 Breast 2 Sarcoma 1 Plasma cell 1 CNS 1

Conditions

Sarcoma 53 Leiomyosarcoma 15 Osteosarcoma 14 Neoplasm Metastasis 8 Breast Neoplasms 8 Pancreatic Neoplasms 7 Bone Neoplasms 7 Small Cell Lung Carcinoma 5 Rhabdomyosarcoma 5 Ovarian Neoplasms 5 Neoplasms 5 Liposarcoma 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma, Synovial 4 Sarcoma, Ewing 4 Prostatic Neoplasms 4 Histiocytoma, Malignant Fibrous 4 Hemangiosarcoma 4 Colonic Neoplasms 4 Chondrosarcoma 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Dermatofibrosarcoma 3 Uterine Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2

Interventions

Cyclophosphamide 36 Peripheral Blood Stem Cell Transplantation 25 fludarabine phosphate 24 Filgrastim 22 Cyclosporine 21 Busulfan 21 Mycophenolic Acid 19 Radiotherapy 18 Antilymphocyte Serum 18 Melphalan 14 Whole-Body Irradiation 13 Methylprednisolone 13 Tacrolimus 11 Cord Blood Stem Cell Transplantation 11 Methotrexate 10 Etoposide 8 Sirolimus 5 Rituximab 5 Bevacizumab 5 aldesleukin 4 Thiotepa 4 Temozolomide 4 Granulocyte Colony-Stimulating Factor 4 sargramostim 3 Topotecan 3 Therapeutics 3 Polymerase Chain Reaction 3 Irinotecan 3 Cytarabine 3 Carmustine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡